A sample of Stanford Pharma Testosterone Cypionate was submitted for independent laboratory analysis to verify its composition and potency. The sample was submitted and the testing was funded by Stanford Pharma (Manufacturer). The analysis aimed to assess the presence and concentration of Testosterone Cypionate, as well as screen for heavy metal contamination.
The test results indicated that the product contained 203.56 mg/ml of Testosterone Cypionate. Additionally, a separate heavy metal analysis was conducted, and no detectable levels of arsenic (As), cadmium (Cd), mercury (Hg), or lead (Pb) were found.
Given that this testing was funded by the manufacturer, potential conflicts of interest should be considered. Manufacturer-funded testing may be subject to sample selection bias, as companies may selectively submit batches that meet expected quality standards. Cross-referencing with third-party-funded analysis is recommended for a more comprehensive assessment.
Detailed Report
Product Overview
- Manufacturer: Stanford Pharma
- Product Name: Testosterone Cypionate
- Batch Number: Unknown
- Expiration Date: Unknown
- Delivery Method: Injectable
Sample Acquisition and Testing
- Task Number: #58305 / #57946
- Testing Ordered: 03 FEB 2025
- Sample Received: 14 FEB 2025
- Analysis Conducted By: Janoshik
- Product Submitted By: Stanford Pharma (Manufacturer)
- Analysis Paid For By: Stanford Pharma (Manufacturer)
Testing Results
| Component/Test | Specification (Label Claim) | Measured Concentration | Accuracy (%) | Variance (%) | Compliance/Remarks |
|---|
| Testosterone Cypionate | 200 mg/ml | 203.56 mg/ml | 101.78% | +1.78% | Meets expected range |
Heavy Metal Analysis Results:
| Element | Result |
|---|---|
| Arsenic (As) | Not detected |
| Cadmium (Cd) | Not detected |
| Mercury (Hg) | Not detected |
| Lead (Pb) | Not detected |
Verification Details
- Verification URL: https://janoshik.com/tests/58305_NRKZT4ETWPK4
- Heavy Metal Analysis Verification URL: https://janoshik.com/tests/57946_VAACQ4YW97BD
Evaluation of Manufacturer-Funded Testing
Since Stanford Pharma funded this testing, it is important to recognize the potential for sample selection bias. Manufacturers may submit only high-quality batches for analysis, which might not represent the consistency of all products on the market. While the results indicate that this batch meets expectations, independent third-party verification is recommended for a broader quality assessment.
Conclusion
The laboratory analysis of Stanford Pharma Testosterone Cypionate confirmed a measured concentration of 203.56 mg/ml, aligning with the expected 200 mg/ml specification. Additionally, the product was free from detectable heavy metal contaminants, which supports its safety profile.
However, manufacturer-funded testing should always be interpreted with caution, as it does not account for potential batch-to-batch variability. Consumers should consider seeking third-party, independently funded lab results for a more comprehensive evaluation of product consistency.
Disclaimer
This report is published for educational and harm reduction purposes. While independent testing provides valuable insights, findings pertain solely to the analyzed batch and may not reflect overall product consistency. Consumers are encouraged to critically assess this information alongside additional independent analyses for informed decision-making.
